A multicenter, randomized, double-blind, placebo-controlled, 3-parallel-group comparison trial to investigate the effect of nalmefene on alcohol consumption reduction in patients with alcohol dependence (phase 3 trial)

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, 3-parallel-group comparison trial to investigate the effect of nalmefene on alcohol consumption reduction in patients with alcohol dependence (phase 3 trial)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Nalmefene (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 25 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top